Metabolic syndrome risk found to be five times higher in males than in females

FHS
July 12, 2023
11:46 pm

Risk of metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke and Type 2 diabetes, doubled in people during the growth period from adolescence to young adulthood, according to researchers from the University of Eastern Finland and University of Exeter in the U.K.

Melpida by Elpida Therapeutics for Paraplegia: Likelihood of Approval – Pharmaceutical Technology

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

November 4, 2023

Apellis’ eye disease drug gets safety label update for rare inflammation side effect

The FDA and Apellis Pharmaceuticals have updated the label for Syfovre — an injection for late-stage wet age-related macular degeneration — to address the potential

December 2, 2023

U-M researchers receive prestigious award for developing breakthrough surgical technology

A team of researchers from the University of Michigan’s College of Engineering and Medical School invented and developed histotripsy, and their efforts to bring it

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.